Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ca/Mg to Prevent Oxaliplatin Neurotoxicity
NCT01099449Phase 3Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Jun 2010
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of calcium gluconate, magnesium sulfate in peripheral neuropathy, sponsored by Cancer and Leukemia Group B. Started Jun 2010; status: completed.
02
Drugs
calcium gluconatemagnesium sulfate
03
Conditions
peripheral neuropathy
Beyond the preview
Go deeper on NCT01099449.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01099449.